Short Interest in Balchem Co. (NASDAQ:BCPC) Expands By 10.9%

Balchem Co. (NASDAQ:BCPC) saw a large growth in short interest in November. As of November 15th, there was short interest totalling 490,300 shares, a growth of 10.9% from the October 31st total of 442,200 shares. Based on an average daily trading volume, of 118,300 shares, the days-to-cover ratio is currently 4.1 days. Approximately 1.5% of the company’s shares are sold short.

Balchem Stock Down 2.0 %

NASDAQ BCPC traded down $3.56 during trading on Tuesday, hitting $177.52. The company’s stock had a trading volume of 26,433 shares, compared to its average volume of 109,669. Balchem has a fifty-two week low of $124.34 and a fifty-two week high of $186.03. The company has a debt-to-equity ratio of 0.21, a current ratio of 2.98 and a quick ratio of 1.90. The company has a market cap of $5.77 billion, a PE ratio of 48.68, a P/E/G ratio of 5.39 and a beta of 0.67. The business’s 50 day simple moving average is $174.56 and its 200-day simple moving average is $167.78.

Analyst Ratings Changes

Several research analysts recently issued reports on BCPC shares. HC Wainwright increased their price objective on Balchem from $185.00 to $190.00 and gave the stock a “buy” rating in a research note on Monday, November 4th. StockNews.com upgraded Balchem from a “hold” rating to a “buy” rating in a research note on Monday, October 28th.

Institutional Trading of Balchem

Large investors have recently added to or reduced their stakes in the company. Westside Investment Management Inc. purchased a new stake in shares of Balchem in the 3rd quarter valued at $27,000. nVerses Capital LLC acquired a new stake in Balchem during the third quarter worth about $35,000. Wilmington Savings Fund Society FSB purchased a new position in Balchem during the third quarter valued at approximately $35,000. GAMMA Investing LLC lifted its holdings in Balchem by 73.4% in the third quarter. GAMMA Investing LLC now owns 841 shares of the basic materials company’s stock valued at $148,000 after acquiring an additional 356 shares during the period. Finally, Blue Trust Inc. boosted its holdings in Balchem by 642.5% during the third quarter. Blue Trust Inc. now owns 839 shares of the basic materials company’s stock worth $148,000 after buying an additional 726 shares in the last quarter. Hedge funds and other institutional investors own 87.91% of the company’s stock.

Balchem Company Profile

Balchem Corporation develops, manufactures, and markets specialty performance ingredients and products for the nutritional, food, pharmaceutical, animal health, medical device sterilization, plant nutrition, and industrial markets worldwide. It operates through three segments: Human Nutrition and Health, Animal Nutrition and Health, and Specialty Products.